Dow Up 0.36% Nasdaq Up 0.12%

More On CANF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Can-Fite BioPharma Ltd. (CANF)

-NYSE MKT
3.73 0.05(1.33%) Aug 21, 4:00PM EDT
Prev Close:3.78
Open:3.68
Bid:3.41 x 1000
Ask:6.30 x 500
1y Target Est:28.00
Beta:1.009
Next Earnings Date:N/A
Day's Range:3.65 - 3.86
52wk Range:3.30 - 9.46
Volume:5,850
Avg Vol (3m):35,283
Market Cap:30.37M
P/E (ttm):N/A
EPS (ttm):-1.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CANF

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.07
Quarterly EPS Est (Jun-14) :-0.36
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Can-Fite BioPharma, Ltd., a clinical-stage biotechnology company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback